GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » Inventory Turnover

Lifecore Biomedical (Lifecore Biomedical) Inventory Turnover : 0.38 (As of May. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Lifecore Biomedical's Cost of Goods Sold for the three months ended in May. 2023 was $17.1 Mil. Lifecore Biomedical's Average Total Inventories for the quarter that ended in May. 2023 was $44.8 Mil. Lifecore Biomedical's Inventory Turnover for the quarter that ended in May. 2023 was 0.38.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lifecore Biomedical's Days Inventory for the three months ended in May. 2023 was 238.81.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lifecore Biomedical's Inventory-to-Revenue for the quarter that ended in May. 2023 was 1.75.


Lifecore Biomedical Inventory Turnover Historical Data

The historical data trend for Lifecore Biomedical's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical Inventory Turnover Chart

Lifecore Biomedical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.09 2.00 0.96 1.46 1.96

Lifecore Biomedical Quarterly Data
Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.74 0.45 0.34 0.38

Lifecore Biomedical Inventory Turnover Calculation

Lifecore Biomedical's Inventory Turnover for the fiscal year that ended in May. 2023 is calculated as

Inventory Turnover (A: May. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: May. 2023 ) / ((Total Inventories (A: May. 2022 ) + Total Inventories (A: May. 2023 )) / count )
=75.284 / ((36 + 40.841) / 2 )
=75.284 / 38.4205
=1.96

Lifecore Biomedical's Inventory Turnover for the quarter that ended in May. 2023 is calculated as

Inventory Turnover (Q: May. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: May. 2023 ) / ((Total Inventories (Q: Feb. 2023 ) + Total Inventories (Q: May. 2023 )) / count )
=17.106 / ((48.696 + 40.841) / 2 )
=17.106 / 44.7685
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifecore Biomedical  (NAS:LFCR) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lifecore Biomedical's Days Inventory for the three months ended in May. 2023 is calculated as:

Days Inventory =Average Total Inventories (Q: May. 2023 )/Cost of Goods Sold (Q: May. 2023 )*Days in Period
=44.7685/17.106*365 / 4
=238.81

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lifecore Biomedical's Inventory to Revenue for the quarter that ended in May. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: May. 2023 ) / Revenue (Q: May. 2023 )
=44.7685 / 25.521
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Lifecore Biomedical Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecore Biomedical (Lifecore Biomedical) Business Description

Traded in Other Exchanges
N/A
Address
3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid.
Executives
Raymond T. White director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Christopher S Kiper director 12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway director C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Wynnefield Partners Small Cap Value Lp I 10 percent owner 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Raymond H Diradoorian director C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter director C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg officer: Chief Financial Officer C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall officer: Executive Vice President 3515 LYMAN BLVD., CHASKA MN 55318